0 XP   0   0   0

Emerald Health Therapeutics Inc
Buy or Sell?

Welcome Invester! I guess you are interested in Emerald Health Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Emerald Health Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Emerald Health Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Emerald Health Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Emerald Health Therapeutics Inc. The closing price on 2022-09-26 was $0.031 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Emerald Health Therapeutics Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficiently in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-erm debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Emerald Health Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Emerald Health Therapeutics Inc:

  • The MRQ is -223.4%. The company is making a huge loss. -2
  • The TTM is -354.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-223.4%TTM-354.8%+131.4%
TTM-354.8%YOY-297.5%-57.3%
TTM-354.8%5Y-747.5%+392.7%
5Y-747.5%10Y-637.8%-109.7%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-223.4%0.9%-224.3%
TTM-354.8%1.1%-355.9%
YOY-297.5%1.7%-299.2%
5Y-747.5%0.8%-748.3%
10Y-637.8%1.4%-639.2%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Emerald Health Therapeutics Inc:

  • The MRQ is -5.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-15.6%+10.1%
TTM-15.6%YOY-10.2%-5.4%
TTM-15.6%5Y-10.6%-5.0%
5Y-10.6%10Y-9.0%-1.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.5%0.2%-5.7%
TTM-15.6%0.2%-15.8%
YOY-10.2%0.2%-10.4%
5Y-10.6%--10.6%
10Y-9.0%0.2%-9.2%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Emerald Health Therapeutics Inc:

  • The MRQ is -6.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.7%TTM-19.0%+12.3%
TTM-19.0%YOY-13.4%-5.6%
TTM-19.0%5Y-14.1%-4.8%
5Y-14.1%10Y-11.9%-2.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.7%0.8%-7.5%
TTM-19.0%0.6%-19.6%
YOY-13.4%0.6%-14.0%
5Y-14.1%0.1%-14.2%
10Y-11.9%0.5%-12.4%

1.2. Operating Efficiency of Emerald Health Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Emerald Health Therapeutics Inc:

  • The MRQ is -263.3%. The company is operating very inefficient. -2
  • The TTM is -244.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-263.3%TTM-244.5%-18.8%
TTM-244.5%YOY-226.3%-18.2%
TTM-244.5%5Y-708.7%+464.2%
5Y-708.7%10Y-608.9%-99.9%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-263.3%3.9%-267.2%
TTM-244.5%2.3%-246.8%
YOY-226.3%4.0%-230.3%
5Y-708.7%3.6%-712.3%
10Y-608.9%1.9%-610.8%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Emerald Health Therapeutics Inc:

  • The MRQ is 4.534. The company is inefficiently in keeping operating costs low. -1
  • The TTM is 5.139. The company is inefficiently in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.534TTM5.139-0.605
TTM5.139YOY5.163-0.024
TTM5.1395Y9.589-4.450
5Y9.58910Y8.195+1.394
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5341.488+3.046
TTM5.1391.437+3.702
YOY5.1631.383+3.780
5Y9.5891.364+8.225
10Y8.1951.159+7.036

1.3. Liquidity of Emerald Health Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1.5 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Emerald Health Therapeutics Inc:

  • The MRQ is 2.983. The company is able to pay all its short-erm debts. +1
  • The TTM is 3.072. The company is very able to pay all its short-erm debts. +2
Trends
Current periodCompared to+/- 
MRQ2.983TTM3.072-0.089
TTM3.072YOY3.667-0.595
TTM3.0725Y3.896-0.824
5Y3.89610Y3.797+0.099
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9831.884+1.099
TTM3.0721.899+1.173
YOY3.6672.092+1.575
5Y3.8962.148+1.748
10Y3.7971.834+1.963
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (assets that can be sold/used right now like cash).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Emerald Health Therapeutics Inc:

  • The MRQ is 0.188. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.198. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.188TTM0.198-0.009
TTM0.198YOY0.347-0.150
TTM0.1985Y0.197+0.001
5Y0.19710Y0.156+0.041
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1880.636-0.448
TTM0.1980.778-0.580
YOY0.3470.807-0.460
5Y0.1970.829-0.632
10Y0.1560.823-0.667

1.4. Solvency of Emerald Health Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Emerald Health Therapeutics Inc:

  • The MRQ is 0.179. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.183. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.179TTM0.183-0.005
TTM0.183YOY0.241-0.058
TTM0.1835Y0.212-0.028
5Y0.21210Y0.311-0.100
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1790.429-0.250
TTM0.1830.413-0.230
YOY0.2410.391-0.150
5Y0.2120.393-0.181
10Y0.3110.397-0.086
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Emerald Health Therapeutics Inc:

  • The MRQ is 0.218. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.226. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.218TTM0.226-0.008
TTM0.226YOY0.342-0.116
TTM0.2265Y0.288-0.062
5Y0.28810Y0.264+0.024
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2180.696-0.478
TTM0.2260.678-0.452
YOY0.3420.624-0.282
5Y0.2880.681-0.393
10Y0.2640.691-0.427

2. Market Valuation of Emerald Health Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Emerald Health Therapeutics Inc:

  • The EOD is -0.239. Company is losing money. -2
  • The MRQ is -0.285. Company is losing money. -2
  • The TTM is -0.334. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.239MRQ-0.285+0.046
MRQ-0.285TTM-0.334+0.050
TTM-0.334YOY-0.740+0.405
TTM-0.3345Y-8.755+8.421
5Y-8.75510Y-8.860+0.105
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.2390.349-0.588
MRQ-0.2850.368-0.653
TTM-0.3341.362-1.696
YOY-0.7403.708-4.448
5Y-8.7556.153-14.908
10Y-8.8606.618-15.478
2.2. Price Earnings to Growth Ratio
  • Measures how expensive or cheap the stock is compared to its predicted growth
  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Emerald Health Therapeutics Inc:

  • The MRQ is 0.011. Very good. +2
  • The TTM is 0.017. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.011TTM0.017-0.006
TTM0.017YOY0.009+0.008
TTM0.0175Y-0.073+0.090
5Y-0.07310Y-0.0730.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0110.003+0.008
TTM0.0170.019-0.002
YOY0.0090.031-0.022
5Y-0.0730.025-0.098
10Y-0.0730.026-0.099

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Emerald Health Therapeutics Inc:

  • The EOD is 0.238. Very good. +2
  • The MRQ is 0.284. Very good. +2
  • The TTM is 0.324. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.238MRQ0.284-0.046
MRQ0.284TTM0.324-0.040
TTM0.324YOY0.524-0.200
TTM0.3245Y0.215+0.109
5Y0.21510Y0.165+0.050
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.2381.380-1.142
MRQ0.2841.617-1.333
TTM0.3242.043-1.719
YOY0.5242.270-1.746
5Y0.2151.999-1.784
10Y0.1651.522-1.357

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Emerald Health Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.1300.164-20%0.335-61%0.183-29%0.141-7%
Current Ratio--2.9833.072-3%3.667-19%3.896-23%3.797-21%
Debt To Asset Ratio--0.1790.183-2%0.241-26%0.212-15%0.311-43%
Debt To Equity Ratio--0.2180.226-4%0.342-36%0.288-24%0.264-17%
Eps---0.009-0.032+272%-0.043+396%-0.076+768%-0.061+601%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.885+13%
Net Profit Margin---2.234-3.548+59%-2.975+33%-7.475+235%-6.378+186%
Operating Margin---2.633-2.445-7%-2.263-14%-7.087+169%-6.089+131%
Operating Ratio--4.5345.139-12%5.163-12%9.589-53%8.195-45%
Pb Ratio0.238-19%0.2840.324-12%0.524-46%0.215+32%0.165+72%
Pe Ratio-0.239+16%-0.285-0.334+17%-0.740+160%-8.755+2974%-8.860+3011%
Peg Ratio--0.0110.017-33%0.009+32%-0.073+741%-0.073+741%
Price Per Share0.031-19%0.0370.055-32%0.171-78%1.252-97%1.106-97%
Quick Ratio--0.1880.198-5%0.347-46%0.197-4%0.156+21%
Return On Assets---0.055-0.156+184%-0.102+85%-0.106+92%-0.090+64%
Return On Equity---0.067-0.190+183%-0.134+100%-0.141+111%-0.119+78%
 EOD+2 -1MRQTTM+10 -5YOY+9 -65Y+9 -610Y+11 -5

3.2. Fundamental Score

Let's check the fundamental score of Emerald Health Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.239
Price to Book Ratio (EOD)Between0-10.238
Net Profit Margin (MRQ)Greater than0-2.234
Operating Margin (MRQ)Greater than0-2.633
Quick Ratio (MRQ)Greater than10.188
Current Ratio (MRQ)Greater than12.983
Debt To Asset Ratio (MRQ)Less than10.179
Debt to Equity Ratio (MRQ)Less than10.218
Return On Equity (MRQ)Greater than0.15-0.067
Return on Assets (MRQ)Greater than0.05-0.055
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Emerald Health Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.840
Ma 20Greater thanMa 500.034
Ma 50Greater thanMa 1000.035
Ma 100Greater thanMa 2000.035
OpenGreater thanClose0.031
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Research Development  640-195445-74371-159212-221-9
Gross Profit  -307-222-529-4,088-4,6173,541-1,0761,15983
Total Other Income Expense Net -10,2955,203-5,0921,911-3,1813,141-40338298



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets33,906
Total Liabilities6,069
Total Stockholder Equity27,837
 As reported
Total Liabilities 6,069
Total Stockholder Equity+ 27,837
Total Assets = 33,906

Assets

Total Assets33,906
Total Current Assets18,104
Long-term Assets18,104
Total Current Assets
Cash And Cash Equivalents 15,518
Net Receivables 1,144
Total Current Assets  (as reported)18,104
Total Current Assets  (calculated)16,662
+/- 1,442
Long-term Assets
Property Plant Equipment 14,842
Long Term Investments 131
Intangible Assets 402
Other Assets 427
Long-term Assets  (as reported)15,802
Long-term Assets  (calculated)15,802
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,069
Long-term Liabilities0
Total Stockholder Equity27,837
Total Current Liabilities
Accounts payable 1,820
Other Current Liabilities 492
Total Current Liabilities  (as reported)6,069
Total Current Liabilities  (calculated)2,312
+/- 3,757
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock252,651
Retained Earnings -253,329
Other Stockholders Equity 606
Total Stockholder Equity (as reported)27,837
Total Stockholder Equity (calculated)-72
+/- 27,909
Other
Capital Stock252,651
Common Stock Shares Outstanding 213,472
Net Invested Capital 27,837
Net Tangible Assets 27,435
Net Working Capital 12,035



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
> Total Assets 
647
701
1,354
3,108
12,127
45,211
37,008
73,731
123,125
204,330
202,637
206,963
240,030
257,110
262,102
156,621
156,723
143,065
134,545
98,274
81,943
67,458
56,308
40,892
39,268
33,906
33,90639,26840,89256,30867,45881,94398,274134,545143,065156,723156,621262,102257,110240,030206,963202,637204,330123,12573,73137,00845,21112,1273,1081,354701647
   > Total Current Assets 
0
0
0
1,999
8,733
28,591
19,462
46,136
91,941
78,315
70,402
63,783
48,041
45,312
45,351
15,725
13,815
17,607
79,987
55,041
57,293
42,743
32,955
22,155
20,482
18,104
18,10420,48222,15532,95542,74357,29355,04179,98717,60713,81515,72545,35145,31248,04163,78370,40278,31591,94146,13619,46228,5918,7331,999000
       Cash And Cash Equivalents 
7
9
666
2,394
11,082
27,890
18,244
44,523
89,504
72,676
52,905
36,042
15,665
2,615
6,389
2,525
581
1,073
418
25,998
31,297
26,886
21,981
18,512
16,152
15,518
15,51816,15218,51221,98126,88631,29725,9984181,0735812,5256,3892,61515,66536,04252,90572,67689,50444,52318,24427,89011,0822,39466697
       Net Receivables 
0
0
0
16
46
104
180
278
393
874
9,615
16,611
2,013
2,659
20,203
1,925
1,105
1,247
1,557
22,278
1,323
2,398
1,766
1,634
1,471
1,144
1,1441,4711,6341,7662,3981,32322,2781,5571,2471,1051,92520,2032,6592,01316,6119,6158743932781801044616000
       Other Current Assets 
15
21
24
25
29
53
143
325
772
1,186
1,509
1,942
1,087
981
31
201
201
0
207
50
18,160
7,502
3,087
0
0
0
0003,0877,50218,160502070201201319811,0871,9421,5091,186772325143532925242115
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
191,989
211,798
216,751
140,896
142,908
125,458
54,558
43,233
24,650
24,715
23,353
18,737
18,786
15,802
15,80218,78618,73723,35324,71524,65043,23354,558125,458142,908140,896216,751211,798191,989000000000000
       Property Plant Equipment 
338
451
429
394
439
929
1,405
3,803
6,011
14,821
18,176
27,276
40,639
48,852
55,314
55,435
54,684
51,498
49,268
40,451
22,200
21,589
20,839
17,605
17,616
14,842
14,84217,61617,60520,83921,58922,20040,45149,26851,49854,68455,43555,31448,85240,63927,27618,17614,8216,0113,8031,405929439394429451338
       Goodwill 
0
0
0
0
0
0
0
169
169
169
169
169
169
169
169
169
169
169
169
0
0
0
0
0
0
0
00000001691691691691691691691691691691691690000000
       Long Term Investments 
0
0
0
0
0
15,601
15,950
20,574
20,007
20,830
24,664
25,943
56,923
71,431
70,129
64,683
67,858
68,856
473
134
0
496
537
254
247
131
131247254537496013447368,85667,85864,68370,12971,43156,92325,94324,66420,83020,00720,57415,95015,60100000
       Intangible Assets 
0
0
0
33
29
24
19
2,852
2,676
87,999
87,029
86,613
91,243
93,922
93,699
19,526
19,213
4,159
3,921
1,859
1,791
1,666
1,100
401
418
402
4024184011,1001,6661,7911,8593,9214,15919,21319,52693,69993,92291,24386,61387,02987,9992,6762,85219242933000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
6,632
211,798
216,751
140,896
0
0
0
0
0
0
0
0
0
0
0000000000140,896216,751211,7986,632000000000000
> Total Liabilities 
1,328
709
410
353
661
14,859
6,873
5,944
3,397
26,348
30,735
36,464
65,924
54,421
67,718
53,454
51,344
52,748
54,377
26,168
11,232
10,655
8,466
7,242
8,935
6,069
6,0698,9357,2428,46610,65511,23226,16854,37752,74851,34453,45467,71854,42165,92436,46430,73526,3483,3975,9446,87314,8596613534107091,328
   > Total Current Liabilities 
1,328
709
410
353
661
14,859
6,873
5,626
3,265
26,348
30,735
36,170
60,969
49,513
39,900
26,984
23,301
24,328
26,942
22,664
11,034
10,477
8,368
7,202
8,935
6,069
6,0698,9357,2028,36810,47711,03422,66426,94224,32823,30126,98439,90049,51360,96936,17030,73526,3483,2655,6266,87314,8596613534107091,328
       Short-term Debt 
0
0
0
0
0
0
0
0
0
2,564
2,537
2,503
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000002,5032,5372,564000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
2,564
2,537
2,503
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000002,5032,5372,564000000000
       Accounts payable 
155
189
156
280
454
534
359
1,379
1,183
1,524
5,570
10,922
12,224
12,208
16,265
7,498
11,738
12,517
14,406
6,301
2,659
2,960
2,896
1,043
1,788
1,820
1,8201,7881,0432,8962,9602,6596,30114,40612,51711,7387,49816,26512,20812,22410,9225,5701,5241,1831,379359534454280156189155
       Other Current Liabilities 
0
0
0
73
207
14,325
6,515
4,248
2,081
22,191
22,309
22,729
45,719
28,907
22,812
13,155
10,272
11,811
10,796
9,446
103
673
79
171
946
492
492946171796731039,44610,79611,81110,27213,15522,81228,90745,71922,72922,30922,1912,0814,2486,51514,32520773000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
4,955
4,908
27,818
27,767
28,043
28,420
27,435
3,504
198
178
98
40
0
0
0040981781983,50427,43528,42028,04327,76727,8184,9084,955000000000000
       Other Liabilities 
0
0
0
0
0
0
0
317
133
0
0
294
294
294
294
0
0
0
0
0
0
0
0
0
0
0
00000000000294294294294001333170000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
253
103
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001032530000000
> Total Stockholder Equity
0
0
944
2,755
11,466
30,352
30,134
65,830
117,908
175,829
171,903
170,498
169,510
198,270
190,173
103,933
106,290
91,309
81,327
73,459
72,070
56,803
47,842
33,650
30,333
27,837
27,83730,33333,65047,84256,80372,07073,45981,32791,309106,290103,933190,173198,270169,510170,498171,903175,829117,90865,83030,13430,35211,4662,75594400
   Retained Earnings -253,329-251,017-247,700-234,533-225,389-210,042-207,148-199,283-187,792-168,930-164,196-74,027-56,774-56,499-52,856-38,956-28,682-22,738-17,829-11,121-9,234-5,803-5,048000
   Accumulated Other Comprehensive Income 00000000000000000000000000
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue9,679
Cost of Revenue-16,137
Gross Profit-6,458-6,458
 
Operating Income (+$)
Gross Profit-6,458
Operating Expense-30,411
Operating Income-20,732-36,869
 
Operating Expense (+$)
Research Development1,727
Selling General Administrative11,294
Selling And Marketing Expenses-
Operating Expense30,41113,021
 
Net Interest Income (+$)
Interest Income298
Interest Expense-700
Net Interest Income-402-402
 
Pretax Income (+$)
Operating Income-20,732
Net Interest Income-402
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-39,167-2,699
EBIT - interestExpense = -21,432
-39,167
-38,467
Interest Expense700
Earnings Before Interest and Taxes (ebit)-20,732-38,467
Earnings Before Interest and Taxes (ebitda)-35,613
 
After tax Income (+$)
Income Before Tax-39,167
Tax Provision-0
Net Income From Continuing Ops-39,167-39,167
Net Income-39,167
Net Income Applicable To Common Shares-39,406
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-18,033402
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SMME.OTCQB
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of SMME.OTCQB.

SMME.OTCQB Daily Candlestick Chart
SLNO.NASDAQ
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of SLNO.NASDAQ.

SLNO.NASDAQ Daily Candlestick Chart
SIG.NYSE
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SIG.NYSE.

SIG.NYSE Daily Candlestick Chart
SLGN.NASDAQ
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SLGN.NASDAQ.

SLGN.NASDAQ Daily Candlestick Chart
SJW.NYSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SJW.NYSE.

SJW.NYSE Daily Candlestick Chart
SJIV.NYSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SJIV.NYSE.

SJIV.NYSE Daily Candlestick Chart
SHG.NYSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHG.NYSE.

SHG.NYSE Daily Candlestick Chart
SFT.NASDAQ
now

I found you a STOCH Bearish Hidden Divergence on the daily chart of SFT.NASDAQ.

SFT.NASDAQ Daily Candlestick Chart
SEER.NASDAQ
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of SEER.NASDAQ.

SEER.NASDAQ Daily Candlestick Chart
SHC.NASDAQ
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of SHC.NASDAQ.

SHC.NASDAQ Daily Candlestick Chart
SGC.NASDAQ
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of SGC.NASDAQ.

SGC.NASDAQ Daily Candlestick Chart
SEM.NYSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SEM.NYSE.

SEM.NYSE Daily Candlestick Chart
SCPH.NASDAQ
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of SCPH.NASDAQ.

SCPH.NASDAQ Daily Candlestick Chart
SB.NYSE
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of SB.NYSE.

SB.NYSE Daily Candlestick Chart
SBFM.NASDAQ
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SBFM.NASDAQ.

SBFM.NASDAQ Daily Candlestick Chart
SCM.NYSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SCM.NYSE.

SCM.NYSE Daily Candlestick Chart
SAP.NYSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SAP.NYSE.

SAP.NYSE Daily Candlestick Chart
PSRUSA.SW
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PSRUSA.SW.

PSRUSA.SW Daily Candlestick Chart
VUKE.LSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VUKE.LSE.

VUKE.LSE Daily Candlestick Chart
JPE.LSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of JPE.LSE.

JPE.LSE Daily Candlestick Chart
UKW.LSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UKW.LSE.

UKW.LSE Daily Candlestick Chart
HAYD.LSE
1 minute ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of HAYD.LSE.

HAYD.LSE Daily Candlestick Chart
FSFL.LSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FSFL.LSE.

FSFL.LSE Daily Candlestick Chart
EPIC.LSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EPIC.LSE.

EPIC.LSE Daily Candlestick Chart
BSIF.LSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BSIF.LSE.

BSIF.LSE Daily Candlestick Chart